Loading…

Treatment-Free Survival after Immune Checkpoint Inhibitor Therapy vs. Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Saved in:

Bibliographic Details
Published in:	Clinical cancer research 2021-11, Vol.27 (24), p.6687-6695
Main Authors:	Regan, Meredith M., Jegede, Opeyemi A., Mantia, Charlene M., Powles, Thomas, Werner, Lillian, Motzer, Robert J., Tannir, Nizar M., Lee, Chung-Han, Tomita, Yoshihiko, Voss, Martin H., Plimack, Elizabeth R., Choueiri, Toni K., Rini, Brian I., Hammers, Hans J., Escudier, Bernard, Albiges, Laurence, Huo, Stephen, Del Tejo, Viviana, Stwalley, Brian, Atkins, Michael B., McDermott, David F.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!